Research from Ph.D. candidate Bohan Chen in the lab of Idse Heemskerk of the Department of Cell and Developmental Biology at ...

Open Molecules 2025, an unprecedented dataset of molecular simulations, has been released to the scientific community, paving ...

The plant, Raven Butene-1 at 9520 East Freeway, reported a process upset incident at about 6:40 p.m. The facility said flames, flaring, and smoke may be noticeable to the community, as crews ...

"Arcanum Infrastructure, LLC (The Company) has announced that a brief ground flaring event involving its Raven Butane-1 facility in Baytown, TX occurred at approximately 6:45 PM Central Time today.

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.

The model has Tatum finishing with 24.1 points in its projections. Banchero haș scored more than 30 points in each of the first two games of the series, which has led to an inflated prop total on ...

The cutting-edge A14 node will allow for highly advanced 1.4nm chips that are likely to be utilized for future generations of Apple silicon. Compared to TSMC's N2 node, A14 promises up to 15% ...

OpenAI has announced the release of its multimodal image generation model, gpt-image-1, to the API, allowing developers and businesses to integrate image creation capabilities directly into their ...

One major surprise the model is calling for at the Zurich Classic 2025: Morikawa and Kitayama, who've combined for seven wins on the PGA Tour, barely crack the top five. Another surprise: Brice ...

Toward the end of March, OpenAI said it intended to release its first “open” language model since GPT‑2 sometime ... that Llama has racked up over 1 billion downloads.

OpenAI has made its multimodal image generation model, GPT-Image-1, available to developers through the API. Previously limited to ChatGPT, the model is now being adopted by companies including Adobe ...

Shaily Engineering Plastics Ltd. shares are in focus on Tuesday, April 22, after Eli Lilly and Company said the phase 3 trial for its once-daily oral small molecule GLP-1 was successful. Lilly's oral ...